|
1
|
Sleep restriction for 1 week reduces insulin sensitivity in healthy men.
|
Diabetes
|
2010
|
2.81
|
|
2
|
Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.
|
Endocrinology
|
2014
|
2.17
|
|
3
|
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
|
J Clin Endocrinol Metab
|
2007
|
1.78
|
|
4
|
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.
|
Circulation
|
2008
|
1.73
|
|
5
|
Effect of acute aldosterone administration on gene expression profile in the heart.
|
Endocrinology
|
2006
|
1.58
|
|
6
|
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
|
Hypertension
|
2013
|
1.55
|
|
7
|
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
|
Endocrinology
|
2006
|
1.34
|
|
8
|
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter.
|
Hypertension
|
2012
|
1.30
|
|
9
|
Aldosterone production and insulin resistance in healthy adults.
|
J Clin Endocrinol Metab
|
2010
|
1.23
|
|
10
|
Hypoglycemia increases serum interleukin-6 levels in healthy men and women.
|
Diabetes Care
|
2008
|
1.18
|
|
11
|
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
|
Circulation
|
2003
|
1.12
|
|
12
|
Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.11
|
|
13
|
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
|
Hypertension
|
2002
|
1.10
|
|
14
|
Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus.
|
J Clin Endocrinol Metab
|
2007
|
1.09
|
|
15
|
Low-salt diet increases insulin resistance in healthy subjects.
|
Metabolism
|
2010
|
1.06
|
|
16
|
Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
|
Am J Physiol Heart Circ Physiol
|
2010
|
1.05
|
|
17
|
Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.
|
Heart Fail Rev
|
2005
|
1.05
|
|
18
|
The renin angiotensin aldosterone system and insulin resistance in humans.
|
Curr Hypertens Rep
|
2013
|
1.04
|
|
19
|
A heartfelt response: Oxytocin effects on response to social stress in men and women.
|
Biol Psychol
|
2012
|
1.04
|
|
20
|
Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
|
Endocrinology
|
2010
|
1.03
|
|
21
|
Mineralocorticoid receptor antagonists and the metabolic syndrome.
|
Curr Hypertens Rep
|
2010
|
1.01
|
|
22
|
Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.
|
Neurosci Biobehav Rev
|
2009
|
0.99
|
|
23
|
Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension.
|
J Clin Endocrinol Metab
|
2011
|
0.98
|
|
24
|
Relationship between aldosterone and progesterone in the human menstrual cycle.
|
J Clin Endocrinol Metab
|
2006
|
0.96
|
|
25
|
Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.
|
J Pharmacol Exp Ther
|
2013
|
0.95
|
|
26
|
Abnormal aldosterone physiology and cardiometabolic risk factors.
|
Hypertension
|
2013
|
0.95
|
|
27
|
Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.94
|
|
28
|
Cardiovascular reactivity to work stress predicts subsequent onset of hypertension: the Air Traffic Controller Health Change Study.
|
Psychosom Med
|
2004
|
0.93
|
|
29
|
Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia.
|
Exp Biol Med (Maywood)
|
2008
|
0.91
|
|
30
|
Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk.
|
Hypertension
|
2014
|
0.88
|
|
31
|
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension.
|
Am J Hypertens
|
2012
|
0.87
|
|
32
|
Activation of the mineralocorticoid receptor increases striatin levels.
|
Am J Hypertens
|
2011
|
0.87
|
|
33
|
Cell membrane-associated mineralocorticoid receptors? New evidence.
|
Hypertension
|
2011
|
0.86
|
|
34
|
The relationship between peroxisome proliferator-activated receptor-gamma and renin: a human genetics study.
|
J Clin Endocrinol Metab
|
2010
|
0.86
|
|
35
|
Role of mineralocorticoid receptor in insulin resistance.
|
Curr Opin Endocrinol Diabetes Obes
|
2012
|
0.86
|
|
36
|
Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats.
|
J Endocrinol
|
2008
|
0.85
|
|
37
|
Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity.
|
Eur Heart J
|
2013
|
0.84
|
|
38
|
Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.
|
Am J Cardiol
|
2013
|
0.84
|
|
39
|
Dietary sodium intake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling proteins in heart.
|
J Endocrinol
|
2011
|
0.84
|
|
40
|
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus.
|
J Clin Endocrinol Metab
|
2012
|
0.84
|
|
41
|
Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice.
|
Metabolism
|
2012
|
0.83
|
|
42
|
The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach.
|
Metabolism
|
2011
|
0.83
|
|
43
|
Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.83
|
|
44
|
Experimental hypoglycemia is a human model of stress-induced hyperalgesia.
|
Pain
|
2012
|
0.82
|
|
45
|
Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance.
|
Metabolism
|
2011
|
0.82
|
|
46
|
Protocol for an experimental investigation of the roles of oxytocin and social support in neuroendocrine, cardiovascular, and subjective responses to stress across age and gender.
|
BMC Public Health
|
2009
|
0.81
|
|
47
|
Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia.
|
J Rheumatol
|
2003
|
0.81
|
|
48
|
Dietary sodium alters the prevalence of electrocardiogram determined left ventricular hypertrophy in hypertension.
|
Am J Hypertens
|
2009
|
0.80
|
|
49
|
A statistical model of diurnal variation in human growth hormone.
|
Am J Physiol Endocrinol Metab
|
2003
|
0.79
|
|
50
|
Increased aldosterone among HIV-infected women with visceral fat accumulation.
|
AIDS
|
2009
|
0.79
|
|
51
|
Aldosterone: villain or protector?
|
Hypertension
|
2007
|
0.78
|
|
52
|
Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males.
|
Metabolism
|
2012
|
0.77
|
|
53
|
Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.
|
Curr Hypertens Rep
|
2015
|
0.77
|
|
54
|
Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women.
|
J Clin Endocrinol Metab
|
2007
|
0.76
|
|
55
|
Quantifying Pituitary-Adrenal Dynamics and Deconvolution of Concurrent Cortisol and Adrenocorticotropic Hormone Data by Compressed Sensing.
|
IEEE Trans Biomed Eng
|
2015
|
0.75
|
|
56
|
Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake.
|
Age (Dordr)
|
2012
|
0.75
|
|
57
|
Regulation of the renin-angiotensin-aldosterone system in fibromyalgia.
|
J Rheumatol
|
2002
|
0.75
|